International Journal of Hematology

Search all International Journal of Hematology articles

Volume 118, Issue 2

August 2023

Including PIH articles on Prophylactic or pre-emptive therapies to prevent relapse after allogeneic stem cell transplantation

18 articles in this issue

Mycobacterial spindle cell pseudotumor mimicking Richter transformation in a patient with hairy cell leukemia
Simon Haefliger
Alexandar Tzankov
Images in Hematology 23 June 2023 Pages: 153 - 154
Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation
Shinichi Kako
Progress in Hematology 07 July 2023 Pages: 155 - 157
Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation
Kaito Harada
Progress in Hematology 04 April 2023 Pages: 158 - 168
Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS
Yuho Najima
Progress in Hematology 10 April 2023 Pages: 169 - 182
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Hideki Nakasone
Progress in Hematology 20 February 2023 Pages: 183 - 192
Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
Koji Kawamura
Progress in Hematology 15 April 2023 Pages: 193 - 200
Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients
Rui Wang
Shifeng Jiang
Wenman Wu
Original Article 21 May 2023 Pages: 201 - 209
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects
Michihide Tokuhira
Yuta Kimura
Tatsuya Kawaguchi
Original Article 02 May 2023 Pages: 210 - 220
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice
Satomi Sahashi
Kazuyuki Shimada
Hitoshi Kiyoi
Original Article 02 May 2023 Pages: 221 - 230
Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study
Weiwei Xie
Qian Wang
Yujun Dong
Original Article 29 May 2023 Pages: 231 - 241
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation
Nobuharu Fujii
Makoto Onizuka
JSTCT Transplant Complications Working Group
Original Article 09 June 2023 Pages: 242 - 251
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation
Carolyne Barakat
Yuichiro Inagaki
Yoshiki Akatsuka
Original Article 13 June 2023 Pages: 252 - 266
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
Naoyuki Miyagawa
Hiroaki Goto
Chitose Ogawa
Original Article 01 May 2023 Pages: 267 - 276
The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells
Kenji Okamoto
Toshihiko Imamura
Tomoko Iehara
Original Article 13 May 2023 Pages: 277 - 287
Eltrombopag for tyrosine kinase inhibitors-associated thrombocytopenia in chronic myeloid leukemia
Aamer Aleem
Ghazi Alotaibi
Abrar AlFaifi
Case Report 09 March 2023 Pages: 288 - 291
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation
Kayoko Tao
Yoshihiro Inamoto
Takahiro Fukuda
Case Report 20 February 2023 Pages: 292 - 298
An adult case of refractory autoimmune neutropenia after liver transplantation
Huye Sun
Fumiya Wada
Akifumi Takaori-Kondo
Case Report 21 February 2023 Pages: 299 - 302
Prophylactic effect of tixagevimab–cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma
Hiro Tatetsu
Yusuke Higuchi
Masao Matsuoka
Letter to the Editor 28 June 2023 Pages: 303 - 305

Volume 118, Issue 2

Mycobacterial spindle cell pseudotumor mimicking Richter transformation in a patient with hairy cell leukemia

Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation

Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation

Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS

Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients

Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects

Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice

Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study

Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation

Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation

Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia

The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells

Eltrombopag for tyrosine kinase inhibitors-associated thrombocytopenia in chronic myeloid leukemia

Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation

An adult case of refractory autoimmune neutropenia after liver transplantation

Prophylactic effect of tixagevimab–cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma

Journal navigation